Cover Image
Market Research Report

Platelet and Plasma Market Size By Component, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026

Published by Global Market Insights Inc. Product code 945481
Published Content info 110 Pages
Delivery time: 2-3 business days
Price
Back to Top
Platelet and Plasma Market Size By Component, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026
Published: June 22, 2020 Content info: 110 Pages
Description

Title:
Platelet and Plasma Market Size By Component (Platelets, Plasma), By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Coagulation Factor Deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver Disease), By Distribution Channel (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026.

The platelet and plasma market is set to record considerable growth in coming years due to the increasing occurrence of chronic diseases across the globe. In modern day medical therapies, patients can receive either a pint of complete blood or just specific components present within the blood that are essential to treat particular conditions. This treatment approach, known as a blood component treatment, enables several patients to receive more benefit from a single pint of the donated whole blood.

Blood contains several different components, which includes platelets, red blood cells, plasma, and white blood cells. Today, the demand for platelet and plasma donations is increasing tremendously as they can address particular conditions more effectively.

In platelet donations, platelets are collected from the blood of a donor and then the remaining blood and the components in it are returned back to the donor. These platelets allows blood to clot, and are commonly given to people suffering from leukemia, to people undergoing chemotherapy, and to babies suffering from severe infections.

Similarly, the liquid part of the blood, known as plasma, is collected from the donor with the remaining components of the blood being returned back to the donor. Plasma also effectively helps blood to form clots, and is commonly used to treat people suffering from liver conditions, severe bacterial infections within the blood and burns.

The overall platelet and plasma market is divided into segments based on component, application, distribution channel, and regional landscape.

By component, the market is divided into platelets, and plasma. Among these, the plasma segment is expected to record around 2% CAGR through the forecast timeframe due to the rising usage of plasma in rare chronic diseases such as autoimmune diseases, hemophilia, hereditary angioedema and other infectious diseases.

In terms of application, the market is divided into thrombocytopenia, hemophilia, platelet function disorders, perioperative Indications, coagulation factor deficiencies, other platelet applications, hemorrhage, thrombotic thrombocytopenic purpura, other plasma applications, and liver disease.

Among these, the perioperative indications held around 15% market share in 2019 due to the significant blood loss during major invasive surgeries that is compensated by transfusing platelets in the patients.

Based on distribution channel, the industry is classified into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centers is likely to witness around 2.5% CAGR over the projected timeframe, due to the increasing preference of people towards ambulatory surgeries owing to the quality treatment at affordable prices.

Regionally, the LATAM market held a market value of over $460 million in 2019, owing to the growing incidence of hemophilia, autoimmune disorder, as well as other infectious diseases.

Table of Contents
Product Code: 2737

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data Sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Platelet and plasma industry 360 degree synopsis, 2015 - 2026
    • 2.1.1. Business trends
    • 2.1.2. Component trends
    • 2.1.3. Application trends
    • 2.1.4. Distribution channel trends
    • 2.1.5. Regional trends

Chapter 3. Platelet and Plasma Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2015 - 2026
  • 3.3. Industry ecosystem
    • 3.3.1. Value chain analysis
    • 3.3.2. Distribution channel analysis
  • 3.4. Industry impact forces
    • 3.4.1. Growth drivers
      • 3.4.1.1. Higher number of blood transfusions in Europe
      • 3.4.1.2. Recent advances in therapeutic protein drug development
      • 3.4.1.3. Increasing prevalence of liver diseases in elderly population
      • 3.4.1.4. Exclusive use of plasma for treatment of rare diseases in Europe
      • 3.4.1.5. Fair reimbursement in developed countries
    • 3.4.2. Industry pitfalls & challenges
      • 3.4.2.1. Stringent regulatory policies
      • 3.4.2.2. Affordability issue in APAC and Latin America due to high costs
  • 3.5. Growth potential analysis
    • 3.5.1. By component
    • 3.5.2. By application
    • 3.5.3. By distribution channel
  • 3.6. COVID-19 impact analysis
  • 3.7. Porter's analysis
  • 3.8. PESTEL analysis

Chapter 4. Platelet and Plasma Market, By Component

  • 4.1. Key segment trends
  • 4.2. Platelets
    • 4.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 4.3. Plasma
    • 4.3.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 5. Platelet and plasma Market, By Application

  • 5.1. Key segment trends
  • 5.2. Hemophilia
    • 5.2.1. Market size, by region, 2015-2026 (USD Million)
  • 5.3. Thrombocytopenia
    • 5.3.1. Market size, by region, 2015-2026 (USD Million)
  • 5.4. Perioperative indications
    • 5.4.1. Market size, by region, 2015-2026 (USD Million)
  • 5.5. Platelet function disorders
    • 5.5.1. Market size, by region, 2015-2026 (USD Million)
  • 5.6. Other platelet applications
    • 5.6.1. Market size, by region, 2015-2026 (USD Million)
  • 5.7. Coagulation factor deficiencies
    • 5.7.1. Market size, by region, 2015-2026 (USD Million)
  • 5.8. Thrombotic thrombocytopenic purpura
    • 5.8.1. Market size, by region, 2015-2026 (USD Million)
  • 5.9. Hemorrhage
    • 5.9.1. Market size, by region, 2015-2026 (USD Million)
  • 5.10. Liver disease
    • 5.10.1. Market size, by region, 2015-2026 (USD Million)
  • 5.11. Other plasma applications
    • 5.11.1. Market size, by region, 2015-2026 (USD Million)

Chapter 6. Platelet and Plasma Market, By Distribution Channel

  • 6.1. Key segment trends
  • 6.2. Hospitals
    • 6.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.3. Ambulatory surgical centers
    • 6.3.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.4. Others
    • 6.4.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 7. Platelet and plasma Market, By Region

  • 7.1. Platelet and plasma market share, by region, 2017 & 2024
  • 7.2. North America
    • 7.2.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.2.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.2.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.2.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.2.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.2.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.2.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.2.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.3.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.3.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.3.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.7.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.7.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.8.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.8.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.9.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.9.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.4.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.4.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.4.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.4.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.4.6. China
      • 7.4.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.4.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.4.7.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.7.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.5.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.5.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.5.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.5.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.5.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.5.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.5.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.6.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.6.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.6.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.6.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.6.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.6.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.6.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Strategy Dashboard
  • 8.2. America's Blood Centers
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. American Red Cross
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. American Association of Blood Banks
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Blood Centers of America
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. European Blood Alliance
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Indian Red Cross
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Italian Red Cross
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Japanese Red Cross
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. South African Red Cross Society
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. OneBlood
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis

Data Tables

  • TABLE 1 Platelet and plasma industry 360 degree synopsis, 2015 - 2026
  • TABLE 2 Global platelet and plasma market, 2015 - 2026 (USD Million)
  • TABLE 3 Global platelet and plasma market, by component, 2015 - 2026 (USD Million)
  • TABLE 4 Global platelet and plasma market, by application, 2015 - 2026 (USD Million)
  • TABLE 5 Global platelet and plasma market, by region, 2015 - 2026 (USD Million)
  • TABLE 6 Industry impact forces
  • TABLE 7 Platelets market, by region, 2015 - 2026 (USD Million)
  • TABLE 8 Plasma market, by region, 2015 - 2026 (USD Million)
  • TABLE 9 Hemophilia market, by region, 2015 - 2026 (USD Million)
  • TABLE 10 Thrombocytopenia market, by region, 2015 - 2026 (USD Million)
  • TABLE 11 Perioperative indications market, by region, 2015 - 2026 (USD Million)
  • TABLE 12 Platelet function disorders market, by region, 2015 - 2026 (USD Million)
  • TABLE 13 Other platelet applications market, by region, 2015 - 2026 (USD Million)
  • TABLE 14 Coagulation factor deficiencies market, by region, 2015 - 2026 (USD Million)
  • TABLE 15 Thrombotic thrombocytopenic purpura market, by region, 2015 - 2026 (USD Million)
  • TABLE 16 Hemorrhage market, by region, 2015 - 2026 (USD Million)
  • TABLE 17 Liver disease market, by region, 2015 - 2026 (USD Million)
  • TABLE 18 Other plasma applications market by region, 2015 - 2026 (USD Million)
  • TABLE 19 Hospitals market by region, 2015 - 2026 (USD Million)
  • TABLE 20 Ambulatory surgical centers market by region, 2015 - 2026 (USD Million)
  • TABLE 21 Others market by region, 2015 - 2026 (USD Million)
  • TABLE 22 North America platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 23 North America platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 24 North America platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 25 North America platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 26 U.S. platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 27 U.S. platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 28 U.S. platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 29 Canada platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 30 Canada platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 31 Canada platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 32 Europe platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 33 Europe platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 34 Europe platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 35 Europe platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 36 Germany platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 37 Germany platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 38 Germany platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 39 UK platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 40 UK platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 41 UK platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 42 France platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 43 France platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 44 France platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 45 Italy platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 46 Italy platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 47 Italy platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 48 Spain platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 49 Spain platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 50 Spain platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 51 Asia Pacific platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 52 Asia Pacific platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 53 Asia Pacific platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 54 Asia Pacific platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 55 Japan platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 56 Japan platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 57 Japan platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 58 China platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 59 China platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 60 China platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 61 India platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 62 India platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 63 India platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 64 Latin America platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 65 Latin America platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 66 Latin America platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 67 Latin America platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 68 Brazil platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 69 Brazil platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 70 Brazil platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 71 Mexico platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 72 Mexico platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 73 Mexico platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 74 MEA platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 75 MEA platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 76 MEA platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 77 MEA platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 78 South Africa platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 79 South Africa platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 80 South Africa platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 81 Saudi Arabia platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 82 Saudi Arabia platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 83 Saudi Arabia platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global platelet and plasma market, 2015 - 2026 (USD Million)
  • FIG. 3 Growth potential analysis, by component
  • FIG. 4 Growth potential analysis, by application
  • FIG. 5 Growth potential analysis, by distribution channel
  • FIG. 6 Porter's analysis
  • FIG. 7 PESTEL Analysis
  • FIG. 8 Strategy dashboard
Back to Top